论文部分内容阅读
目的探讨蛛网膜下腔再出血的诱因,采取相应措施达到降低再出血发生率和减少死亡率的目的。方法A组采用脱水降颅压和抗纤溶等常规方法治疗,B组在常规方法治疗的基础上常规使用钙拮抗剂、镇痛剂、镇静剂、腰穿脑脊液置换。对2组蛛网膜下腔出血(SAH)再出血发生率、出血时间、诱因、死亡率及死亡原因进行分析。结果B组再出血发生率显著低于A组p<0.05(x2=4.249)。出血时间、诱因、死亡率及死亡原因无显著性差异。结论SAH患者常规使用钙拮抗剂、镇痛剂、镇静剂、腰穿脑脊液置换能有效降低再出血发生率、但一旦发生再出血,死亡率则无显著性差异。
Objective To explore the causes of subarachnoid hemorrhage and take corresponding measures to reduce the incidence of rebleeding and reduce the mortality. Methods A group was treated by conventional methods such as dehydration intracranial pressure reduction and antifibrinolytic therapy. In group B, calcium antagonists, analgesics, sedatives and lumbar puncture cerebrospinal fluid were routinely used in routine treatment. The incidence of rebleeding, bleeding time, inducement, mortality and causes of death in 2 groups of subarachnoid hemorrhage (SAH) were analyzed. Results The incidence of rebleeding in group B was significantly lower than that in group A (p <0.05) (x2 = 4.249). Bleeding time, incentive, mortality and causes of death no significant difference. Conclusion Conventional use of calcium antagonists, analgesics, sedatives and lumbar puncture and cerebrospinal fluid replacement in SAH patients can effectively reduce the incidence of rebleeding. However, there is no significant difference in the rate of rebleeding after SAH.